Skip to main content
Have a personal or library account? Click to login
Zakażenia Związane Z Opieką Zdrowotną U Pacjentów Oparzonych: OD Patogenezy DO Zintegrowanej Kontroli Zakażeń Cover

Zakażenia Związane Z Opieką Zdrowotną U Pacjentów Oparzonych: OD Patogenezy DO Zintegrowanej Kontroli Zakażeń

Open Access
|Oct 2026

References

  1. Abdi FA, Motumma AN, Kalayu AA, Abegaz WE. Prevalence and antimicrobial-resistant patterns of Pseudomonas aeruginosa among burn patients attending Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia. PLoS One. 2024 Mar;19(3). https://doi.org/10.1371/journal.pone.0289586
  2. Alfadli M, El-Sehsah EM, Ramadan MAM. Risk factors and distribution of MDROs among patients with healthcare associated burn wound infection. Germs. 2018 Dec;8(4):199–206. https://doi.org/10.18683/germs.2018.1147
  3. Armour AD, Shankowsky HA, Swanson T, Lee J, Tredget EE. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J Trauma. 2007 Jul;63(1):164–171. https://doi.org/10.1097/01.TA.0000240175.18189.AF
  4. Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infect. 2020 Jun;9(1):1180–1193. https://doi.org/10.1080/22221751.2020.1769500
  5. Ballard J, Edelman L, Saffle J, Sheridan R, Kagan R, Bracco D, Cancio L, Cairns B, Baker R, Fillari P, et al. Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res. 2008 Jan-Feb;29(1):213–221. https://doi.org/10.1097/BCR.0b013e31815f6ecb
  6. Barajas-Nava LA, López-Alcalde J, Roqué i Figuls M, Solà I, Bonfill Cosp X. Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev. 2013 Jun;2013(6). https://doi.org/10.1002/14651858.CD008738.pub2
  7. Bourgi J, Said JM, Yaakoub C, Atallah B, Al Akkary N, Sleiman Z, Ghanimé G. Bacterial infection profile and predictors among patients admitted to a burn care center: a retrospective study. Burns. 2020 Dec;46(8):1968–1976. https://doi.org/10.1016/j.burns.2020.05.004
  8. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006 Apr;19(2):403–434. https://doi.org/10.1128/CMR.19.2.403-434.2006
  9. Corcione S, Pensa A, Castiglione A, Lupia T, Bortolaso B, Romeo MR, Stella M, De Rosa FG. Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre’s analysis. J Chemother. 2021 Feb;33(1):62–66. https://doi.org/10.1080/1120009X.2020.1780776
  10. de La Cal MA, Cerdá E, García-Hierro P, Lorente L, Sánchez -Concheiro M, Díaz C, van Saene HK. Pneumonia in patients with severe burns: a classification according to the concept of the carrier state. Chest. 2001 Apr;119(4):1160–1165. https://doi.org/10.1378/chest.119.4.1160
  11. Doi Y. Treatment options for carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019 Nov;69(Suppl 7)–S575. https://doi.org/10.1093/cid/ciz830
  12. Dudoignon E, Chevret S, Tsague S, Hamane S, Chaouat M, Plaud B, Vicault E, Mebazaa A, Legrand M, Alanio A, et al. Risk factors and outcome associated with fungal infections in patients with severe burn injury: 10-year retrospective IFI-BURN study. Clin Infect Dis. 2024 Sep;79(3):682–689. https://doi.org/10.1093/cid/ciae337
  13. Eftekhar F, Naseh Z. Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae. Iran J Microbiol. 2015 Jun;7(3):144–149.
  14. Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res. 2007 Dec;126(6): 541–544.
  15. Fleischer M, Zienkiewicz M. Mikrobiologiczne mapowanie szpitala. Forum Zakażeń. 2018 Sep;9(4):213–219. https://doi.org/10.15374/FZ2018041
  16. Gallo L, Kim P, Gallo M, Olaiya O, Main C, Avram R, Bain J, Thoma A, Voineskos SH, Coroneos C. Incidence and risk factors associated with microbial colonization of burn wounds: an observational study. Plast Surg (Oakv). 2025 May;33(2):269–275. https://doi.org/10.1177/22925503231214760
  17. Gandhi AA, Prasad PS, Nataraj G, Puri V. Temporal changes in bacterial profile of burn wound infections in a tertiary care hospital and risk factors for invasion: a prospective cohort study. J Clin Diagn Res. 2025 Jan;19(1)–DC05. https://doi.org/10.7860/JCDR/2025/70627.20461
  18. Gomersall J, Mortimer K, Hassan D, Whitehead KA, Slate AJ, Ryder SF, Chambers LE, El Mohtadi M, Shokrollahi K. Ten--year analysis of bacterial colonisation and outcomes of major burn patients with a focus on Pseudomonas aeruginosa. Microorganisms. 2024 Jan;12(1):42. https://doi.org/10.3390/microorganisms12010042
  19. Güldoğan CE, Kendirci M, Tikici D, Gündoğdu E, Yastı AÇ. Clinical infection in burn patients and its consequences. Ulus Travma Acil Cerrahi Derg. 2017 Nov;23(6):466–471. https://doi.org/10.5505/tjtes.2017.16064
  20. Gur I, Zilbert A, Toledano K, Roimi M, Stern A. Clinical impact of fungal colonization of burn wounds in patients hospitalized in the intensive care unit: a retrospective cohort study. Trauma Surg Acute Care Open. 2024 Apr;9(1). https://doi.org/10.1136/tsaco-2023-001325
  21. Heyland DK, Wischmeyer P, Jeschke MG, Wibbenmeyer L, Turgeon AF, Stelfox HT, Day AG, Garrel D. A randomized trial of enteral glutamine to minimize thermal injury (the RE-ENERGIZE trial): a clinical trial protocol. Scars Burn Heal. 2017 Dec;3:2059513117745241. https://doi.org/10.1177/2059513117745241
  22. Horta R, Tomaz D, Egipto P, Silva A. The outcome of fungal infections in a burn intensive care unit: a study of 172 patients. Ann Burns Fire Disasters. 2020 Jun;33(2):101–106.
  23. Hryniewicz W, Kulig J, Ozorowski T, Mól A, Kulig P, Wąchol D. Stosowanie antybiotyków w wybranych zakażeniach skóry i tkanek miękkich. Warszawa (Polska): Narodowy Instytut Leków; 2012. ISBN 978-83-932196-9-8.
  24. Hu Y, Li D, Xu L, Hu Y, Sang Y, Zhang G, Dai H. Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study. Antimicrob Resist Infect Control. 2021 Jun;10(1):98. https://doi.org/10.1186/s13756-021-00969-w
  25. Huang D, Qi M, Hu Y, Yu M, Liang Z. The impact of Candida spp airway colonization on clinical outcomes in patients with ventilator-associated pneumonia: a systematic review and meta-analysis. Am J Infect Control. 2020 Jun;48(6):695–701. https://doi.org/10.1016/j.ajic.2019.11.002
  26. Kalligeros M, Shehadeh F, Karageorgos SA, Zacharioudakis IM, Mylonakis E. MRSA colonization and acquisition in the burn unit: a systematic review and meta-analysis. Burns. 2019 Nov;45(7):1528–1536. https://doi.org/10.1016/j.burns.2019.05.014
  27. Kiley JL, Greenhalgh DG. Infections in burn patients. Surg Clin North Am. 2023 Jun;103(3):427–437. https://doi.org/10.1016/j.suc.2023.02.005
  28. Knuth CM, Rehou S, Barayan D, Jeschke MG. Evaluating sepsis criteria in detecting alterations in clinical, metabolic, and inflammatory parameters in burn patients. Shock. 2022 Aug;58(2):103– 110. https://doi.org/10.1097/SHK.0000000000001965
  29. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006 Aug;6:130. https://doi.org/10.1186/1471-2334-6-130
  30. Kramer A, Dissemond J, Kim S, Willy C, Mayer D, Papke R, Tuchmann F, Assadian O. Consensus on wound antisepsis: update 2018. Skin Pharmacol Physiol. 2018 Jan;31(1):28–58. https://doi.org/10.1159/000481545
  31. Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017 Dec;65(12):2130–2136. https://doi.org/10.1093/cid/cix682
  32. Lade H, Joo HS, Kim JS. Molecular basis of non-β-lactam antibiotics resistance in Staphylococcus aureus. Antibiotics (Basel). 2022 Oct;11(10):1378. https://doi.org/10.3390/antibiotics11101378
  33. Ladhani HA, Yowler CJ, Claridge JA. Burn wound colonization, infection, and sepsis. Surg Infect (Larchmt). 2021 Feb;22(1):44–48. https://doi.org/10.1089/sur.2020.346
  34. Lam NN, Hung TD, Hung DK. Acute respiratory distress syndrome among severe burn patients in a developing country: application result of the Berlin definition. Ann Burns Fire Disasters. 2018 Mar;31(1):9–12.
  35. Li F, Song M, Xu L, Deng B, Zhu S, Li X. Risk factors for catheter-associated urinary tract infection among hospitalized patients: a systematic review and meta-analysis of observational studies. J Adv Nurs. 2019 Mar;75(3):517–527. https://doi.org/10.1111/jan.13863
  36. Liao C, Huang X, Wang Q, Yao D, Lu W. Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance. Front Cell Infect Microbiol. 2022;12:926758. https://doi.org/10.3389/fcimb.2022.926758
  37. Lindblad M, Huss F, Tano E, Lytsy B, Sütterlin S. Preventing outbreaks in burn units: the role of hygiene compliance and early warning systems. Antimicrob Resist Infect Control. 2025 Jul;14:75. https://doi.org/10.1186/s13756-025-01592-9
  38. Liodaki E, Kalousis K, Mauss KL, Kisch T, Mailaender P, Stang F. Epidemiology of pneumonia in a burn care unit: the influence of inhalation trauma on pneumonia and of pneumonia on burn mortality. Ann Burns Fire Disasters. 2015 Jun;28(2):128–133.
  39. Maraki S, Mantadakis E, Mavromanolaki VE, Kofteridis DP, Samonis G. A 5-year surveillance study on antimicrobial resistance of Acinetobacter baumannii clinical isolates from a tertiary Greek hospital. Infect Chemother. 2016 Sep;48(3):190–198. https://doi.org/10.3947/ic.2016.48.3.190
  40. Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010 Apr;11(5):779–788. https://doi.org/10.1517/14656561003596350
  41. Moins-Teisserenc H, Cordeiro DJ, Audigier V, Ressaire Q, Benyamina M, Lambert J, Maki G, Homyrda L, Toubert A, Legrand M. Severe altered immune status after burn injury is associated with bacterial infection and septic shock. Front Immunol. 2021 Mar;12:586195. https://doi.org/10.3389/fimmu.2021.586195
  42. Mortada H, Alhindi N, Abukhudair A, Alanazi S, AlSahli A, Arab K. The effects of glutamine supplementation on reducing mortality and morbidity among burn patients: a systematic review and meta-analysis of randomized controlled trials. JPRAS Open. 2023 Mar;35:6–17. https://doi.org/10.1016/j.jpra.2022.09.003
  43. Mosier MJ, Pham TN, Klein MB, Gibran NS, Arnoldo BD, Gamelli RL, Tompkins RG, Herndon DN. Early enteral nutrition in burns: compliance with guidelines and associated outcomes in a multicenter study. J Burn Care Res. 2011 Jan–Feb;32(1):104–109. https://doi.org/10.1097/BCR.0b013e318204b3be
  44. Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in burns. Surg Infect (Larchmt). 2016 Apr;17(2):250–255. https://doi.org/10.1089/sur.2013.134
  45. Oehmcke S, Shannon O, Mörgelin M, Herwald H. Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta. 2010 Sep;411(17–18):1172–1180. https://doi.org/10.1016/j.cca.2010.04.032
  46. Oleszczak-Momot W, Jurkiewicz A. Kontrola wewnętrzna dzia-łań zapobiegających szerzeniu się zakażeń i chorób zakaźnych w podmiotach leczniczych w świetle obowiązujących aktów prawnych. Med Og Nauk Zdr. 2015;21(2):142–145. https://doi.org/10.5604/20834543.1152910
  47. Özkurt Z, Altoparlak Ü, Yılmaz Sİ, Erol S, Özden K, Akçay MN. Reducing hospital infection rates in the burn unit by adherence to infection control measures: a six-year experience. Turk J Med Sci. 2012 Feb;42(1):17–24. https://doi.org/10.3906/sag-1005-824
  48. Ozlu O, Basaran A. Infections in patients with major burns: a retrospective study of a burn intensive care unit. J Burn Care Res. 2022 Jul;43(4):926–930. https://doi.org/10.1093/jbcr/irab222
  49. Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016 Jun;80(3):629– 661. https://doi.org/10.1128/MMBR.00078-15
  50. Palackic A, Popp D, Tapking C, Houschyar KS, Branski LK. Fungal infections in burn patients. Surg Infect (Larchmt). 2021 Feb;22(1):83–87. https://doi.org/10.1089/sur.2020.299
  51. Pawlik K, Mączyńska A, Fleischer M, Hryniewicz W. Kontrola środowiska szpitalnego w zapobieganiu zakażeniom wywoływanym przez wieloantybiotykooporne patogeny alarmowe. Warszawa (Polska): Narodowy Instytut Leków; 2020. ISBN 978-83-949636-4-4.
  52. Peck MD. Epidemiology of burns throughout the world. Part I: distribution and risk factors. Burns. 2011 Nov;37(7):1087–1100. https://doi.org/10.1016/j.burns.2011.06.005
  53. Perween N, Prakash SK, Siddiqui O. Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res. 2015 Sep;9(9)–DC16. https://doi.org/10.7860/JCDR/2015/13837.6576
  54. Petersen-Morfin S, Bocanegra-Ibarias P, Morfin-Otero R, Garza-González E, Perez-Gomez HR, González-Diaz E, Esparza-Ahumada S, León-Garnica G, Amezcua-Salazar G, Rodriguez-Noriega E. New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae isolated from a burned patient. Am J Case Rep. 2017 Jul;18:805–809. https://doi.org/10.12659/AJCR.903992
  55. Pruskowski KA, Rizzo JA, Cancio LC. Fungal infections in burn patients from 2014–2019: a 5-year retrospective review. J Burn Care Res. 2020 Mar;41(Suppl 1)–S91. https://doi.org/10.1093/jbcr/iraa024.140
  56. Raes K, Blot K, Vogelaers D, Labeau S, Blot S. Protective isolation precautions for the prevention of nosocomial colonisation and infection in burn patients: a systematic review and meta-analysis. Intensive Crit Care Nurs. 2017 Oct;42:22–29. https://doi.org/10.1016/j.iccn.2017.03.005
  57. Ramos GE. Antibiotic prophylaxis in burn patients: a review of current trends and recommendations for treatment. J Infectiology. 2018;1(1):1–5. https://doi.org/10.29245/2689-9981/2018/1.1105
  58. Robben PM, Ayalew MD, Chung KK, Ressner RA. Multidrug-resistant organisms in burn infections. Surg Infect (Larchmt). 2021 Feb;22(1):103–112. https://doi.org/10.1089/sur.2020.129
  59. Roy S, Mukherjee P, Kundu S, Majumder D, Raychaudhuri V, Choudhury L. Microbial infections in burn patients. Acute Crit Care. 2024 May;39(2):214–225. https://doi.org/10.4266/acc.2023.01571
  60. Ruegsegger L, Xiao J, Naziripour A, Kanumuambidi T, Brown D, Williams F, Marshall SH, Rudin SD, Yen K, Chu T, et al. Multidrug-resistant Gram-negative bacteria in burn patients. Antimicrob Agents Chemother. 2022 Sep;66(9). https://doi.org/10.1128/aac.00688-22
  61. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005 Oct;33(10):2184–2193. https://doi.org/10.1097/01.CCM.0000181731.53912.D9
  62. Salmani A, Shakerimoghaddam A, Pirouzi A, Delkhosh Y, Eshraghi M. Correlation between biofilm formation and antibiotic susceptibility pattern in Acinetobacter baumannii MDR isolates retrieved from burn patients. Gene Rep. 2020 Dec;21:100816. https://doi.org/10.1016/j.genrep.2020.100816
  63. Sánchez M, Herruzo R, Marbán A, Araujo P, Asensio MJ, Leyva F, Casado C, García-de-Lorenzo A. Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients. J Burn Care Res. 2012 May–Jun;33(3):386–392. https://doi.org/10.1097/BCR.0b013e318231df95
  64. Sen S, Johnston C, Greenhalgh D, Palmieri T. Ventilator-associated pneumonia prevention bundle significantly reduces the risk of ventilator-associated pneumonia in critically ill burn patients. J Burn Care Res. 2016 May–Jun;37(3):166–171. https://doi.org/10.1097/BCR.0000000000000228
  65. Sharma BR. Infection in patients with severe burns: causes and prevention thereof. Infect Dis Clin North Am. 2007 Sep;21(3):745– 759. https://doi.org/10.1016/j.idc.2007.06.003
  66. Shokoohizadeh L, Ekrami A, Labibzadeh M, Ali L, Alavi SM. Antimicrobial resistance patterns and virulence factors of enterococci isolates in hospitalized burn patients. BMC Res Notes. 2018 Jan;11(1):1. https://doi.org/10.1186/s13104-017-3088-5
  67. Shupp JW, Pavlovich AR, Jeng JC, Pezzullo JC, Oetgen WJ, Jaskille AD, Jordan MH, Shoham S. Epidemiology of bloodstream infections in burn-injured patients: a review of the National Burn Repository. J Burn Care Res. 2010 Jul–Aug;31(4):521–528. https://doi.org/10.1097/BCR.0b013e3181e4d5e7
  68. Singh NP, Rani M, Gupta K, Sagar T, Kaur IR. Changing trends in antimicrobial susceptibility pattern of bacterial isolates in a burn unit. Burns. 2017 Aug;43(5):1083–1087. https://doi.org/10.1016/j.burns.2017.01.016
  69. Skibba KE, Mitchell DC, Bell DE. The effective elimination of nosocomial burn wound infections with daily wound care. J Burn Care Res. 2019 Apr;40(Suppl 1)–S104. https://doi.org/10.1093/jbcr/irz013.173
  70. Sopata M, Mrozikiewicz-Rakowska B, Jawień A, Woroń J, Malka M, Karpiński TM, Sobieszek-Kundro A, Gabriel M, Mańkowski P, Szewczyk MT, et al. Stanowisko Polskiego Towarzystwa Leczenia Ran – postępowanie przeciwdrobnoustrojowe w ranie skolonizowanej, z cechami infekcji i zagrożonej infekcją w erze antybiotykooporności. Leczenie Ran. 2023;20(4):125–141. https://doi.org/10.60075/lr.v20i4.59
  71. Styczyński J, Dzierżanowska-Fangrat K, Matysiak M, Kałwak K, Irga-Jaworska N, Szczepański T. Program racjonalnej terapii przeciwgrzybiczej „WYLECZ!”. Forum Zakażeń. 2021;12(3):133–138. https://doi.org/10.15374/FZ2021016
  72. Sulik-Tyszka B, Wróblewska M. Aspergiloza – diagnostyka laboratoryjna i leczenie. Forum Zakażeń. 2021;12(3):123–131. https://doi.org/10.15374/FZ2021013
  73. Surowiecka A. Sprawozdanie ze spotkania grupy roboczej ds. leczenia oparzeń pod patronatem Krajowego Konsultanta w dziedzinie chirurgii plastycznej i Dyrektora Departamentu Lecznictwa w Ministerstwie Zdrowia. Chir Plast Oparzenia. 2025;13(1):35–39. https://doi.org/10.15374/ChPiO2025005
  74. Tao W, Xu G, Zhou J, Luo Y, Li PS. Glutamine supplementation on burn patients: a systematic review and meta-analysis. J Burn Care Res. 2024 May–Jun;45(3):675–684. https://doi.org/10.1093/jbcr/irae007
  75. Tejiram S, Shupp JW. Innovations in infection prevention and treatment. Surg Infect (Larchmt). 2021 Feb;22(1):12–19. https://doi.org/10.1089/sur.2020.202
  76. Thomas RE, Thomas BC. Reducing biofilm infections in burn patients’ wounds and biofilms on surfaces in hospitals, medical facilities and medical equipment to improve burn care: a systematic review. Int J Environ Res Public Health. 2021 Dec;18(24):13195. https://doi.org/10.3390/ijerph182413195
  77. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 Feb;32(2):101–114. https://doi.org/10.1086/657912
  78. Wanis M, Walker SAN, Daneman N, Elligsen M, Palmay L, Simor A, Cartotto R. Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center. Burns. 2016 Feb;42(1):104–111. https://doi.org/10.1016/j.burns.2015.07.010
  79. Wibbenmeyer L, Danks R, Faucher L, Amelon M, Latenser B, Kealey GP, Herwaldt LA. Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Care Res. 2006 Mar–Apr;27(2):152–160. https://doi.org/10.1097/01.BCR.0000203359.32756.F7
  80. Yeong EK, Sheng WH. Does early bloodstream infection pose a significant risk of in-hospital mortality in adults with burns? J Microbiol Immunol Infect. 2022 Feb;55(1):95–101. https://doi.org/10.1016/j.jmii.2021.01.004
  81. Zhao H, Liu M, Wu J, Chen S, Yang H, Long J, Duan G. Mortality and genetic diversity of antibiotic-resistant bacteria associated with bloodstream infections: a systemic review and genomic analysis. BMC Infect Dis. 2024 Dec;24(1):1385. https://doi.org/10.1186/s12879-024-10274-7
  82. Zheng XX, Kong LA, Lyu R, Xu CJ. Analysis of epidemiological characteristics and risk factors of catheter-associated urinary tract infections in patients with perineal and/or hip burns. Chin J Burns Wounds. 2024 Mar;40(3):289–295. https://doi.org/10.3760/cma.j.cn501225-20231027-00138
  83. Zhou HY, Yuan Z, Du YP. Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis. Int J Infect Dis. 2014 May;22:25–30. https://doi.org/10.1016/j.ijid.2014.01.018
DOI: https://doi.org/10.2478/am-2026-0015 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 174 - 188
Submitted on: Jan 8, 2026
Accepted on: Sep 14, 2026
Published on: Oct 13, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Weronika A. Czapska, Anna Chrapusta, Agnieszka Gniadek, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.